RU2022101891A3 - - Google Patents

Download PDF

Info

Publication number
RU2022101891A3
RU2022101891A3 RU2022101891A RU2022101891A RU2022101891A3 RU 2022101891 A3 RU2022101891 A3 RU 2022101891A3 RU 2022101891 A RU2022101891 A RU 2022101891A RU 2022101891 A RU2022101891 A RU 2022101891A RU 2022101891 A3 RU2022101891 A3 RU 2022101891A3
Authority
RU
Russia
Application number
RU2022101891A
Other languages
Russian (ru)
Other versions
RU2022101891A (ru
Filing date
Publication date
Application filed filed Critical
Publication of RU2022101891A publication Critical patent/RU2022101891A/ru
Publication of RU2022101891A3 publication Critical patent/RU2022101891A3/ru

Links

RU2022101891A 2016-06-07 2017-06-06 Способы применения cd32b x cd79b-связывающих молекул при лечении воспалительных заболеваний и расстройств RU2022101891A (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201662346717P 2016-06-07 2016-06-07
US62/346,717 2016-06-07
US201662432328P 2016-12-09 2016-12-09
US62/432,328 2016-12-09

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU2018145971A Division RU2772434C2 (ru) 2016-06-07 2017-06-06 Способы применения cd32b x cd79b-связывающих молекул при лечении воспалительных заболеваний и расстройств

Publications (2)

Publication Number Publication Date
RU2022101891A RU2022101891A (ru) 2022-02-07
RU2022101891A3 true RU2022101891A3 (cg-RX-API-DMAC10.html) 2025-06-24

Family

ID=60578080

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2022101891A RU2022101891A (ru) 2016-06-07 2017-06-06 Способы применения cd32b x cd79b-связывающих молекул при лечении воспалительных заболеваний и расстройств

Country Status (11)

Country Link
US (1) US20190322741A1 (cg-RX-API-DMAC10.html)
EP (1) EP3464378A4 (cg-RX-API-DMAC10.html)
JP (3) JP2019521103A (cg-RX-API-DMAC10.html)
KR (3) KR20250021614A (cg-RX-API-DMAC10.html)
CN (1) CN109311990A (cg-RX-API-DMAC10.html)
AU (1) AU2017278329B2 (cg-RX-API-DMAC10.html)
BR (1) BR112018075303A2 (cg-RX-API-DMAC10.html)
MX (2) MX2018015265A (cg-RX-API-DMAC10.html)
RU (1) RU2022101891A (cg-RX-API-DMAC10.html)
TW (1) TW201742633A (cg-RX-API-DMAC10.html)
WO (1) WO2017214096A1 (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201790719A1 (ru) * 2014-09-26 2017-07-31 Макродженикс, Инк. Биспецифические моновалентные диатела, которые способны связывать cd19 и cd3, а также их применения
EP3532497B1 (en) * 2016-10-26 2024-07-24 The Board of Trustees of the Leland Stanford Junior University Modified immunoglobulin hinge regions to reduce hemagglutination
JP2022513338A (ja) * 2018-10-03 2022-02-07 ネペンザ・バイオサイエンシズ・エルエルシー 抗cd79抗体およびその使用
CN114502587A (zh) * 2019-07-30 2022-05-13 普瑞文森生物有限公司 通过非耗竭性b细胞抑制剂降低免疫原性的方法和组合物
KR20220091458A (ko) * 2019-07-30 2022-06-30 프로벤션 바이오, 인코포레이티드 비-고갈성 b 세포 억제제에 의한 면역원성을 감소시키기 위한 방법 및 조성물
WO2021207681A1 (en) * 2020-04-10 2021-10-14 The Board Of Trustees Of The Leland Stanford Junior University Targeted reduction of activated immune cells
KR20230113312A (ko) * 2020-11-01 2023-07-28 프로벤션 바이오, 인코포레이티드 루푸스 치료 방법 및 조성물
CA3231174A1 (en) * 2021-08-02 2023-02-09 Innovent Biologics (Suzhou) Co., Ltd. Anti-cd79bxcd3 bispecific antibody and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9963510B2 (en) * 2005-04-15 2018-05-08 Macrogenics, Inc. Covalent diabodies and uses thereof
US9284375B2 (en) * 2005-04-15 2016-03-15 Macrogenics, Inc. Covalent diabodies and uses thereof
US11384149B2 (en) * 2013-08-09 2022-07-12 Macrogenics, Inc. Bi-specific monovalent Fc diabodies that are capable of binding CD32B and CD79b and uses thereof
UA116479C2 (uk) * 2013-08-09 2018-03-26 Макродженікс, Інк. БІСПЕЦИФІЧНЕ МОНОВАЛЕНТНЕ Fc-ДІАТІЛО, ЯКЕ ОДНОЧАСНО ЗВ'ЯЗУЄ CD32B I CD79b, ТА ЙОГО ЗАСТОСУВАННЯ
AU2016207758C1 (en) * 2015-01-13 2020-05-28 New Zealand Institute For Bioeconomy Science Limited Agricultural composition

Similar Documents

Publication Publication Date Title
CN309940542S (zh) 婴儿成长椅
BR102025006099A2 (pt) Método implementado por computador
BR102024017758A2 (pt) Derivado piridil-tiazolidinona jc-21a com atividade fungicida frente candida auris e toxicidade dérmica em ratos
BR102024017388A2 (pt) Dispositivo de remover e dispositivo de colocar engrenagem
BR102024017432A2 (pt) Dispositivo simulador para treinamento de cuidados médicos
CN308973633S (zh) 首饰盒(j)
CN309015940S (zh) 按键保护套(十字型)
CN308732305S (zh) 艺术花架
CN308403600S (zh) 面料(bmhq27)
CN308403607S (zh) 面料(ly-20252)
CN308570569S (zh) 凉拖鞋(lmd-6017)
CN308556445S (zh) 伞头(tf6310夹勾式)
CN308407025S (zh) 草坪灯(精灵b款)
CN308404230S (zh) 果盘(沥水)
CN308405665S (zh) 插头(Plug03)
CN308403999S (zh) 转角置物架(吸盘波纹)
CN308404204S (zh) 杯子(2406)
CN308407808S (zh) 鞋面(鳄鱼纹元素)
CN308406064S (zh) 电路板(触控变色笔)
CN308407764S (zh) 拖鞋
CN308403985S (zh) 安全柜
CN308403711S (zh) 沙发(9113)
CN308403984S (zh) 置物架(花影)
CN308403144S (zh) 衣服(线条纹)
CN308403137S (zh) 上衣(皮毛一体68532)